Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/13225
Title: | Neuroendocrine responses to single doses of buspirone in obsessive-compulsive disorder. | Austin Authors: | Norman, Trevor R ;Apostolopoulos, M;Burrows, Graham D;Judd, F K | Affiliation: | Department of Psychiatry, University of Melbourne, Austin Hospital, Victoria, Australia | Issue Date: | 16-May-1994 | Publication information: | International Clinical Psychopharmacology; 9(2): 89-94 | Abstract: | Prolactin and cortisol responses to buspirone, a partial serotonin agonist with effects on the 5-HT1A receptor, were measured in 16 patients with DSM-III-R obsessive-compulsive disorder (OCD) and 16 normal controls. No consistent differences were observed between patients and controls with respect to the hormone responses measured. The results suggest that dysfunction of the 5-HT1A receptor is not present in OCD patients. The limitations of buspirone as a specific agonist challenge of the 5-HT1A receptor are discussed. Although data from other studies generally support a serotonin dysfunction in OCD, the question of which specific subtype(s) of receptor remains unanswered. | Gov't Doc #: | 8056999 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/13225 | Journal: | International clinical psychopharmacology | URL: | https://pubmed.ncbi.nlm.nih.gov/8056999 | Type: | Journal Article | Subjects: | Adult Buspirone.adverse effects.therapeutic use Female Humans Hydrocortisone.secretion Male Obsessive-Compulsive Disorder.drug therapy.physiopathology Prolactin.secretion Receptors, Serotonin.drug effects |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.